Ocugen (OCGN) Other Non Operating Income (2014 - 2026)
Ocugen (OCGN) posted Other Non Operating Income of -$150000.0 for Q1 2026, down 131.45% on a QoQ basis from $477000.0 in Q4 2025, and down 330.77% year-over-year from $65000.0 in Q1 2025.
Ocugen (OCGN) Other Non Operating Income (2014 - 2026) Analysis & Trends
Ocugen's Other Non Operating Income history runs 11 years deep, the most recent figure standing at -$150000.0 for Q1 2026.
- Quarterly Other Non Operating Income fell 330.77% year-over-year to -$150000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$927000.0 (down 496.15% YoY) and the FY2025 annual result came in at -$664000.0, down 574.29% from the prior year.
- Other Non Operating Income was -$150000.0 for Q1 2026 at Ocugen, down from $477000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $477000.0 in Q4 2025 and bottomed at -$1.3 million in Q3 2025.
- A 4-year average of -$108285.7 and a median of $15000.0 in 2022 frame the typical range for Other Non Operating Income.
- Peak annual rise in Other Non Operating Income reached 211.76% in 2025, while the deepest fall reached 132000.0% in 2025.
- Ocugen's Other Non Operating Income stood at $15000.0 in 2022, then jumped by 920.0% to $153000.0 in 2024, then jumped by 211.76% to $477000.0 in 2025, then plunged by 131.45% to -$150000.0 in 2026.
- Business Quant data shows OCGN's Other Non Operating Income at -$150000.0 in Q1 2026, $477000.0 in Q4 2025, and -$1.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -150,000.00 |
| Dec 31, 2025 | 477,000.00 |
| Sep 30, 2025 | -1.32 Mn |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 153,000.00 |
| Sep 30, 2024 | 1,000.00 |
| Mar 31, 2022 | 15,000.00 |
| Dec 31, 2021 | 336,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Jun 30, 2021 | -332,000.00 |
| Mar 31, 2021 | -20,000.00 |
| Dec 31, 2019 | -32,507.00 |
| Sep 30, 2019 | -18.51 Mn |
| Jun 30, 2019 | -608,149.00 |
| Mar 31, 2019 | -416.00 |
| Dec 31, 2018 | 1.50 Mn |
| Sep 30, 2018 | 1.46 Mn |
| Jun 30, 2018 | -26,000.00 |
| Mar 31, 2018 | -24,000.00 |
| Dec 31, 2017 | 26,000.00 |